Holen Sie sich die Stockscreener-App
13.34
5.79%
-0.82
Handel nachbörslich:
13.00
-0.34
-2.55%
Schlusskurs vom Vortag:
$14.16
Offen:
$14.17
24-Stunden-Volumen:
826.70K
Relative Volume:
0.69
Marktkapitalisierung:
$1.04B
Einnahmen:
$1.53B
Nettoeinkommen (Verlust:
$40.23M
KGV:
26.68
EPS:
0.5
Netto-Cashflow:
$60.93M
1W Leistung:
-9.86%
1M Leistung:
-13.32%
6M Leistung:
-23.42%
1J Leistung:
-30.77%
1-Tages-Spanne:
$13.18
$14.35
1-Wochen-Bereich:
$13.18
$14.98
52-Wochen-Spanne:
$11.06
$27.13
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Firmenname
Integra Lifesciences Holdings Corp
Sektor
Branche
Telefon
(609) 275-0500
Adresse
1100 CAMPUS ROAD, PRINCETON, NJ
Vergleichen Sie IART mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
13.34 | 1.10B | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-31 | Hochstufung | Argus | Hold → Buy |
| 2024-12-02 | Eingeleitet | Morgan Stanley | Underweight |
| 2024-10-07 | Hochstufung | BTIG Research | Sell → Neutral |
| 2024-07-30 | Herabstufung | BTIG Research | Neutral → Sell |
| 2024-07-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2024-05-07 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-05-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-12-05 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | Eingeleitet | CL King | Buy |
| 2023-08-24 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-08 | Herabstufung | Argus | Buy → Hold |
| 2023-05-24 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-07-25 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2021-12-17 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-09-15 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-05-27 | Eingeleitet | Citigroup | Neutral |
| 2020-04-03 | Eingeleitet | SunTrust | Buy |
| 2020-01-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | Eingeleitet | SunTrust | Buy |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-08-07 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | Hochstufung | BTIG Research | Neutral → Buy |
| 2018-07-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2018-01-02 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-05-02 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | Eingeleitet | UBS | Buy |
Alle ansehen
Integra Lifesciences Holdings Corp Aktie (IART) Neueste Nachrichten
How Integra LifeSciences Holdings Corporation (IL3) stock compares with market leaders2025 Performance Recap & AI Forecast Swing Trade Picks - newser.com
Real time breakdown of Integra LifeSciences Holdings Corporation stock performanceJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com
Published on: 2025-10-10 04:09:09 - newser.com
Is Integra LifeSciences Holdings Corporation stock positioned for long term growthEarnings Overview Summary & Weekly Sector Rotation Insights - newser.com
Published on: 2025-10-09 06:37:44 - newser.com
Is Integra LifeSciences Holdings Corporation stock reversal real or fakeJuly 2025 Institutional & Risk Controlled Daily Plans - newser.com
Integra LifeSciences (NASDAQ:IART) Receives "Sell (D)" Rating from Weiss Ratings - MarketBeat
What MACD trends signal for Integra LifeSciences Holdings Corporation (IL3) stockJuly 2025 Levels & Real-Time Stock Movement Alerts - newser.com
Oct 11–15: Integra Showcases Durepair, Mayfield Ghost & CUSA, CereLink at CNS in Los Angeles - Stock Titan
Integra LifeSciences Holdings Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
How risky is Integra LifeSciences Holdings Corporation (IL3) stock compared to peersInsider Buying & Expert-Curated Trade Recommendations - newser.com
Is Integra LifeSciences Holdings Corporation (IL3) stock safe for risk averse investorsWeekly Profit Analysis & Low Risk Profit Maximizing Plans - newser.com
Could Integra LifeSciences (IART) Leverage New Clinical Leadership to Advance Its Innovation Agenda? - simplywall.st
How strong dollar benefits Integra LifeSciences Holdings Corporation (IL3) stockJuly 2025 Sector Moves & Free Safe Capital Growth Stock Tips - newser.com
Can Integra LifeSciences Holdings Corporation (IL3) stock deliver consistent EPS growth2025 Technical Patterns & Risk Controlled Daily Trade Plans - newser.com
Why Integra LifeSciences Holdings Corporation stock could see breakout soonJuly 2025 Review & AI Optimized Trade Strategies - newser.com
How Integra LifeSciences Holdings Corporation (IL3) stock trades in high volatilityJuly 2025 Technicals & Safe Entry Trade Reports - newser.com
Integra LifeSciences Holdings Corporation stock momentum explainedMarket Volume Report & Low Drawdown Momentum Trade Ideas - newser.com
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Given Average Recommendation of "Reduce" by Brokerages - MarketBeat
Integra LifeSciences (IART): Assessing Current Valuation After a Recent Share Price Dip - Yahoo Finance
Integra LifeSciences Holdings (IART): Exploring Valuation Opportunities After Recent Share Price Decline - simplywall.st
How resilient is Integra LifeSciences Holdings Corporation stock in market downturnsInflation Watch & Real-Time Buy Signal Alerts - newser.com
What earnings revisions data tells us about Integra LifeSciences Holdings CorporationAnalyst Upgrade & Capital Efficient Trading Techniques - newser.com
How to use a screener to detect Integra LifeSciences Holdings Corporation breakoutsWeekly Earnings Recap & Weekly Top Gainers Trade List - newser.com
Integra LifeSciences (NASDAQ:IART) Stock Price Down 4.1%What's Next? - MarketBeat
Integra LifeSciences Hits Day High with 8.73% Surge in Stock Price - Markets Mojo
Will Integra LifeSciences Holdings Corporation stock beat EPS estimatesJuly 2025 Patterns & Fast Entry and Exit Trade Plans - newser.com
Integra LifeSciences (NASDAQ:IART) Stock Price Up 4.9%What's Next? - MarketBeat
Masimo, Integra LifeSciences, CONMED, IQVIA, and Charles River Laboratories Shares Are Soaring, What You Need To Know - Barchart.com
Finanzdaten der Integra Lifesciences Holdings Corp-Aktie (IART)
Umsatz
Nettogewinn
Free Cashflow
ENV
Integra Lifesciences Holdings Corp-Aktie (IART) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 10 '25 |
Option Exercise |
0.00 |
1,180 |
0 |
2,359 |
| Schwartz Eric | EVP, Chief Legal Officer & Sec |
Dec 03 '24 |
Sale |
24.59 |
4,070 |
100,102 |
59,511 |
1.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):